UTTR1147A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for UTTR1147A, covering 2022-01-10 to 2023-09-29. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]